4th January 2021

AB: NK Maribor player Martin Milec

On 27 August 2020, following the UEFA 2020/21 Europa League match between NK Maribor and Coleraine FC, the NK Maribor player Martin Milec underwent an in-competition doping control carried out by UEFA. The analysis of the player’s sample by a WADA-accredited laboratory revealed the presence of Fenoterol, which is a Beta-2 Agonist that is prohibited at all times pursuant to the 2020 WADA Prohibited List.

Following an initial review, disciplinary proceedings were opened by UEFA against the player on 22 October 2020. On the same day, the chairman of the UEFA Control, Ethics and Disciplinary Body decided to refer these proceedings to the UEFA Appeals Body for a decision pursuant to Article 29(3) of the UEFA Disciplinary Regulations.

The UEFA Appeals Body decided, at its meeting on 19 November 2020, to suspend the player for four months, starting from the notification of the decision (i.e. 19 November 2020) and ending on 19 March 2021, for committing an anti-doping rule violation. No appeal was lodged against the UEFA Appeals Body decision to the Court of Arbitration for Sport and, therefore, the decision is final.

• This media release was published by the Union of European Football Associations (UEFA) on 4 January 2021. Click here for the original.

You may also like...

Pin It on Pinterest

Share This